Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HADHA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
R3HCC1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKAP8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKAP8L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM41B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNAS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR1182 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC19A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SAR1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RCL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFP82 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADIPOR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOSC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRRT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on